Hospitals

Heart Rhythm Clinical and Research Solutions and the Real World Evidence Consortium Launch EVERCOOL AF Study on Attune Medical’s ensoETM®

Retrieved on: 
Thursday, April 4, 2024
Research, Medical Devices, Surgery, Medical Supplies, Hospitals, Cardiology, Other Health, Pharmaceutical, Health, Science, Real, RWE, Atrial fibrillation, Procedural, Multimedia

Heart Rhythm Clinical and Research Solutions (HRCRS) and the Real World Evidence (RWE) Consortium have enrolled the first patient in the REView of ProcEdural FactoRs and Outcomes after Atrial Fibrillation Ablation with Active Esophageal COOLing (EVERCOOL AF) study.

Key Points: 
  • Heart Rhythm Clinical and Research Solutions (HRCRS) and the Real World Evidence (RWE) Consortium have enrolled the first patient in the REView of ProcEdural FactoRs and Outcomes after Atrial Fibrillation Ablation with Active Esophageal COOLing (EVERCOOL AF) study.
  • The study is part of a multi-center observational study evaluating the impact of proactive esophageal cooling on patient outcome, throughput, and experience in high volume centers.
  • This press release features multimedia.
  • View the full release here: https://www.businesswire.com/news/home/20240404481691/en/

Velsera and Flywheel Team up to Support Multimodal Imaging Genomics Research

Retrieved on: 
Thursday, April 4, 2024
Other Health, General Health, Radiology, Pharmaceutical, Medical Devices, Technology, Hospitals, Artificial Intelligence, Genetics, Health Technology, Biotechnology, Health, Genomics, Algorithm, MRI, FHIR, Down syndrome, Environment, Investigation, Disease, Patient, Artificial intelligence, AI, PB, NIH, Ecosystem, Privacy, Government, Syndrome, Metadata, Medical imaging

Combining their capabilities, Velsera, Flywheel, and D3b were able to manage, harmonize, and analyze large datasets in a cloud-based platform.

Key Points: 
  • Combining their capabilities, Velsera, Flywheel, and D3b were able to manage, harmonize, and analyze large datasets in a cloud-based platform.
  • The Velsera team created interoperability standards that allow platforms to communicate with each other and make large-scale data access transparent to the user.
  • “Linking our Flywheel Core Platform with Velsera’s CAVATICA platform facilitates an unparalleled ability to perform advanced, multimodal data analysis in a cloud environment,” said Travis Richardson, Chief Strategist at Flywheel.
  • Using data from D3b, teams were able to analyze the combination of extracted imaging features on the Flywheel Core Platform.

Fortune Media and Great Place To Work Name Vizient to ‘100 Best Companies to Work For’ in 2024

Retrieved on: 
Thursday, April 4, 2024
Professional Services, Pharmaceutical, Business, Medical Devices, Hospitals, Publishing, Data Analytics, Communications, Medical Supplies, Human Resources, Practice Management, Health, Consulting, HR, Culture, Organization, Growth, Face, Consultant, PEOPLE, Trust, Workplace

Great Place To Work® and Fortune magazine have recognized Vizient as one of the Fortune 100 Best Companies to Work For® in 2024.

Key Points: 
  • Great Place To Work® and Fortune magazine have recognized Vizient as one of the Fortune 100 Best Companies to Work For® in 2024.
  • Earning a spot means that Vizient is one of the best companies to work for in the country.
  • The 100 Best Companies to Work For list is the only recognition that focuses on how employees feel about their workplace.
  • Great Place To Work evaluates confidential feedback from employees, matching against HR data from participating companies.

Mission Bio Launches Sample Multiplexing for Tapestri to Unlock Critical Single-Cell Insights for Oncology and Genome Editing Markets

Retrieved on: 
Thursday, April 4, 2024
Health, Hospitals, Genetics, General Health, Clinical Trials, Pharmaceutical, Biotechnology, PCR, Mutation, B cell, DNA, BioLegend, Medicine, Cancer, Hospital, Drug development, Bone marrow, Mission, AOCS, Pathology, Vaccine

Mission Bio , a leader in single-cell multiomic solutions for precision medicine, today introduces sample multiplexing features for the company’s Tapestri Platform.

Key Points: 
  • Mission Bio , a leader in single-cell multiomic solutions for precision medicine, today introduces sample multiplexing features for the company’s Tapestri Platform.
  • Combining multiple samples into a single experiment will help lower this barrier to entry for academic researchers and de-risk the adoption for biopharma.
  • Sample multiplexing by genotyping, unique to Tapestri, uses the genetic information of the relevant variants obtained by bulk next-generation sequencing to distinguish samples.
  • Mission Bio’s multiplexing capabilities make single-cell technology more accessible to the biomedical community and has the potential to dramatically impact patient care in the future.”
    For more information about Tapestri, please visit www.missionbio.com .

Ardent Health Appoints Hospital Operations Leader

Retrieved on: 
Thursday, April 4, 2024
General Health, Other Health, Hospitals, Health, Health Technology, Moses Austin, Growth, Trinity University, Hospital, University, American College, Lovelace Health System, Management

Ardent Health today announced the appointment of David Schultz as president of hospital operations.

Key Points: 
  • Ardent Health today announced the appointment of David Schultz as president of hospital operations.
  • He brings more than 25 years of experience leading hospital and provider group operations, system integration, strategy and growth.
  • “Since joining Ardent a year ago, David has played a key role in enhancing operations and supporting quality care initiatives across the organization,” said Marty Bonick , president and CEO of Ardent.
  • He previously served as senior vice president of operations and service lines for Virginia Mason Franciscan Health in Tacoma, Washington.

Spineology® Appoints new Member to Leadership Team; Spine Veteran Emory Rooney joins as Executive Vice President of Sales

Retrieved on: 
Thursday, April 4, 2024
Medical Devices, Health, Hospitals, Surgery, Physical Therapy, Biotechnology, Freedom, University, Growth, Medicine, Learning, Central Florida, Inc., Area, Patient, Medical device, IDE, Surgeon, ATEC, Spine, Pain

Spineology Inc. ("Spineology" or the "Company"), the leader in ultra-minimally invasive spine surgery, announced today the addition of Emory Rooney as Executive Vice President, Sales.

Key Points: 
  • Spineology Inc. ("Spineology" or the "Company"), the leader in ultra-minimally invasive spine surgery, announced today the addition of Emory Rooney as Executive Vice President, Sales.
  • Rooney comes to Spineology with extensive spine sales experience, having served in Medical Device fields related to spinal implants and navigation for nearly 20 years.
  • “The addition of Emory adds even further conviction about our clear opportunity for growth at Spineology,” said Brian Snider, Chief Executive Officer at Spineology.
  • Prior to joining Spineology, Mr. Rooney spent nearly six years with Alphatec Spine (Nasdaq: ATEC), where he served as the Vice President of Sales, East.

Acadia Healthcare Appoints Dr. Stephanie Eken as Chief Medical Officer

Retrieved on: 
Thursday, April 4, 2024
Mental Health, Health, Hospitals, Physical Therapy, Managed Care, General Health, Psychiatry, Patient, Mental health, Child, University, Adolescence, Pediatrics, Acadia Healthcare, Safety, Multimedia, Medical device

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced the appointment of Dr. Stephanie Eken as the Company’s new chief medical officer.

Key Points: 
  • Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced the appointment of Dr. Stephanie Eken as the Company’s new chief medical officer.
  • View the full release here: https://www.businesswire.com/news/home/20240404108920/en/
    Acadia Healthcare Appoints Dr. Stephanie Eken as Chief Medical Officer (Photo: Business Wire)
    “Acadia is thrilled to welcome Dr. Eken as our new chief medical officer,” said Chris Hunter, Chief Executive Officer of Acadia Healthcare.
  • “This is an exciting time to join Acadia Healthcare,” said Dr. Eken.
  • Dr. Genovese departs Acadia after 10 years with the Company, seven of those as its chief medical officer.

Rpharmy Awarded Drug Information and Surveillance Solutions Agreement With Premier, Inc.

Retrieved on: 
Wednesday, April 3, 2024
Technology, Nursing, Hospitals, Health Technology, Professional Services, Software, Data Analytics, Pharmaceutical, Health, Data Management, USP, Entrepreneurship, Risk, Patient, Knowledge, Hospital, Pharmacist, NIOSH, OSHA, EPA, Pharmacy, Safety, Physician

Rpharmy , a leading provider of medical formulary management and hazardous drug safety information software solutions, has been awarded a national group purchasing agreement for Drug Information and Surveillance Solutions with Premier, Inc.

Key Points: 
  • Rpharmy , a leading provider of medical formulary management and hazardous drug safety information software solutions, has been awarded a national group purchasing agreement for Drug Information and Surveillance Solutions with Premier, Inc.
  • Effective August 1, 2023, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Rpharmy’s Rhazdrugs hazardous drug safety information solution and Formweb, a formulary medication resource solution.
  • “Rpharmy is committed to enhancing the safety of both patients and healthcare workers, aiming to mitigate the risks associated with hazardous drug exposure in hospitals and healthcare settings,” said Laura Paxton, Rpharmy CEO and Co-Founder.
  • With integrated data and analytics, collaboratives, supply chain solutions, consulting and other services, Premier enables better care and outcomes at a lower cost.

P3 Health Partners to Present at the 23rd Annual Needham Virtual Healthcare Conference

Retrieved on: 
Wednesday, April 3, 2024
Practice Management, Nursing, Managed Care, General Health, Health, Hospitals, Health Insurance, Other Health, PIII, Conference

P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that management is scheduled to present at the 23rd Annual Needham Virtual Healthcare Conference on Thursday, April 11, 2024, at 1:30 pm Eastern Time.

Key Points: 
  • P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that management is scheduled to present at the 23rd Annual Needham Virtual Healthcare Conference on Thursday, April 11, 2024, at 1:30 pm Eastern Time.
  • A webcast of the presentation will be available on P3’s Investor Relations Website: https://ir.p3hp.org/ .
  • A replay will be available on P3’s investor relations webpage for 30 days following the presentation.

Recent Research Supports Sedation-Free TNE for Effective Management of GI Disorders Utilizing the EvoEndo System

Retrieved on: 
Wednesday, April 3, 2024
Health, Medical Devices, Hospitals, Health Technology, Other Health, General Health, Biotechnology, Safety, Anesthesia, TNE, Evaluation, Patient, Pediatrics, Efficacy, Abstract, Male, Workflow, EGD, Eosinophilic esophagitis, Endoscopy, Esophagogastroduodenoscopy, Nursing

Recently published scientific abstracts and peer-reviewed papers support the efficacy and demand for gastroenterology programs to offer Sedation-Free Transnasal Endoscopy (TNE) utilizing the EvoEndo System as an alternative to traditional TNE.

Key Points: 
  • Recently published scientific abstracts and peer-reviewed papers support the efficacy and demand for gastroenterology programs to offer Sedation-Free Transnasal Endoscopy (TNE) utilizing the EvoEndo System as an alternative to traditional TNE.
  • Findings suggest a valuable opportunity to optimize the patient experience, minimize risks associated with anesthesia, and improve diagnostic outcomes.
  • There were no adverse events, suggesting promising potential for TNE as a diagnostic tool in assessing esophageal disorders.
  • These studies highlight the advantages of offering unsedated TNE and the viability of broader applications in pediatric endoscopy.